21 results on '"Nieva-Zuluaga, Ane"'
Search Results
2. THU-210 Dysfunctional activation of the DNA damage response is associated with MASLD progression through an E2F2-dependent mechanism
3. FRI-343-YI APAP induced liver damage is prevented by activation of PPARgamma and PPAR-alpha
4. OS-101-YI Remodelling of hepatocyte cholesterol metabolism mediates colorectal liver metastasis
5. TOP-229-YI The E2F2 target glycerophosphodiester phosphodiesterase domain containing 3 is involved in MASLD progression to HCC and related dyslipidemias
6. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis
7. The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH
8. Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism
9. E2F2 deficiency protects from acetaminophen-induced hepatotoxicity while E2F1 is required to prevent the devastating effects
10. E2F2-promoted DNA damage in NASH worsens the metabolic scenario
11. The uptake of extracellular lipids promotes cholangiocarcinoma progression
12. miR34a-5p is a target of E2F2 transcription factor in MAFLD-related HCC
13. Methionine adenosyltransferase 1a antisense oligonucleotides induce the fibroblast growth factor 21-driven recovery from obesity and associated hepatoesteatosis
14. The DNA damage response is involved in the metabolic dysregulation of MAFLD patients via inefficient fatty acid oxidation
15. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis
16. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
17. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
18. WED-408 - E2F2-promoted DNA damage in NASH worsens the metabolic scenario
19. WED-404 - The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH
20. SAT-215 - Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism
21. FRI-395 - E2F2 deficiency protects from acetaminophen-induced hepatotoxicity while E2F1 is required to prevent the devastating effects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.